Efficacy and Safety of Risankizumab for Active Psoriatic Arthritis: 100-Week Results from the Phase 3 KEEPsAKE 1 Randomized Clinical Trial. - Kristensen, Lars Erik; Keiserman, Mauro; Papp, Kim; McCasland, Leslie; White, Douglas; Carter, Kyle; Lippe, Ralph; Photowala, Huzefa; Drogaris, Leonidas; Soliman, Ahmed M.; Chen, Michael; Padilla, Byron; et al. (Rheumatology & Therapy, 2024)